| [1] |
Litière S, Werutsky G, Fentiman IS, et al. Breast conserving therapy versus mastectomy for stage Ⅰ-Ⅱ breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial[J]. Lancet Oncol, 2012, 13(4): 412-419.
|
| [2] |
Brachtel EF, Rusby JE, Michaelson JS, et al. Occult nipple involvement in breast cancer: Clinicopathologic findings in 316 consecutive mastectomy specimens[J]. J Clin Oncol, 2009, 27(30): 4948-4954.
|
| [3] |
Cense HA, Rutgers EJ, Lopes Cardozo M, et al. Nipple-sparing mastectomy in breast cancer: A viable option？[J]. Eur J Surg Oncol, 2001, 27(6): 521-526.
|
| [4] |
Wu Z, Kim H, Lee J, et al. Breast cancer recurrence in the nipple-areola complex after nipple-sparing mastectomy with immediate breast reconstruction for invasive breast cancer[J]. JAMA Surg, 2019, 154(11): 1030-1037.
|
| [5] |
Gerber B, Krause A, Reimer T, et al. Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure[J]. Ann Surg, 2003, 238(1): 120-127.
|
| [6] |
Kim HJ, Park EH, Lim WS, et al. Nipple areola skin-sparing mastectomy with immediate transverse rectus abdominis musculocutaneous flap reconstruction is an oncologically safe procedure: a single center study[J]. Ann Surg, 2010, 251(3): 493-498.
|
| [7] |
Mota BS, Riera R, Ricci MD, et al. Nipple- and areola-sparing mastectomy for the treatment of breast cancer[J]. Cochrane Database Syst Rev，2016，11(11): CD008932.
|
| [8] |
Kissin MW, Kark AE. Nipple preservation during mastectomy[J]. Br J Surg, 1987, 74(1): 58-61.
|
| [9] |
Chen CM, Disa JJ, Sacchini V, et al. Nipple-sparing mastectomy and immediate tissue expander/implant breast reconstruction[J]. Plast Reconstr Surg, 2009, 124(6): 1772-1780.
|
| [10] |
Voltura AM, Tsangaris TN, Rosson GD, et al. Nipple-sparing mastectomy：critical assessment of 51 procedures and implications for selection criteria[J]. Ann Surg Oncol, 2008, 15(12): 3396-3401.
|
| [11] |
方敏，冯拓，吴凯男，等. 保留乳头乳晕乳腺切除术的应用现状及安全性讨论[J]. 转化医学电子杂志，2018, 5(8): 24-27.
|
| [12] |
Seki H, Sakurai T, Mizuno S, et al. A novel nipple-areola complex involvement predictive index for indicating nipple-sparing mastectomy in breast cancer patients[J]. Breast Cancer, 2019, 26(6): 808-816.
|
| [13] |
Schecter AK, Freeman MB, Giri D, et al. Applicability of the nipple-areola complex-sparing mastectomy: A prediction model using mammography to estimate risk of nipple-areola complex involvement in breast cancer patients[J]. Ann Plas Surg, 2006, 56(5): 498-504.
|
| [14] |
Banerjee A, Gupta S, Bhattacharya N. Preservation of nipple-areola complex in breast cancer-a clinicopathological assessment[J]. J Plast Reconstr Aesthet Surg, 2008, 61(10): 1195-1198.
|
| [15] |
Vyas JJ, Chinoy RF, Vaidya JS. Prediction of nipple and areola involvement in breast cancer[J]. Eur J Surg Oncol, 1998, 24(1): 15-16.
|
| [16] |
Steen ST, Chung AP, Han S, et al. Predicting nipple-areolar involvement using preoperative breast MRI and primary tumor characteristics[J]. Ann Surg Oncol, 2013, 20(2): 633-639.
|
| [17] |
Menon RS, van Geel AN. Cancer of the breast with nipple involvement[J]. Br J Cancer, 1989, 59(1): 81-84.
|
| [18] |
Eisenberg RE, Chan JS, Swistel AJ, et al. Pathological evaluation of nipple-sparing mastectomies with emphasis on occult nipple involvement: the Weill-Cornell experience with 325 cases[J]. Breast J, 2014, 20(1): 15-21.
|
| [19] |
D’Alonzo M, Martincich L, Biglia N, et al. Clinical and radiological predictors of nipple-areola complex involvement in breast cancer patients[J]. Eur J Cancer, 2012, 48(15): 2311-2318.
|
| [20] |
Billar JA, Dueck AC, Gray RJ, et al. Preoperative predictors of nipple-areola complex involvement for patients undergoing mastectomy for breast cancer[J]. Ann Surg Oncol, 2011, 18(11): 3123-3128.
|
| [21] |
Pirozzi PR, Rossetti C, Carelli I, et al. Clinical and morphological factors predictive of occult involvement of the nipple-areola complex in mastectomy specimens[J]. Eur J Obstet Gynecol Reprod Biol, 2010, 148(2): 177-181.
|
| [22] |
Weidong L, Shuling W, Xiaojing G, et al. Nipple involvement in breast cancer: Retrospective analysis of 2323 consecutive mastectomy specimens[J]. Int J Surg Pathol, 2011, 19(3): 328-334.
|
| [23] |
Simmons RM, Brennan M, Christos P, et al. Analysis of nipple/areolar involvement with mastectomy: Can the areola be preserved？[J]. Ann Surg Oncol, 2002, 9(2): 165-168.
|
| [24] |
Laronga C, Kemp B, Johnston D, et al. The incidence of occult nipple-areola complex involvement in breast cancer patients receiving a skin-sparing mastectomy[J]. Ann Surg Oncol, 1999, 6(6): 609-613.
|
| [25] |
Wang J, Xiao X, Wang J, et al. Predictors of nipple-areolar complex involvement by breast carcinoma: Histopathologic analysis of 787 consecutive therapeutic mastectomy specimens[J]. Ann Surg Oncol, 2012, 19(4): 1174-1180.
|
| [26] |
Gulben K, Yildirim E, Berberoglu U. Prediction of occult nipple-areola complex involvement in breast cancer patients[J]. Neoplasma, 2009, 56(1): 72-75.
|
| [27] |
Hwang H, Park S, Koo JS, et al. Factors predictive of occult nipple-areolar complex involvement in patients with carcinoma in situ of the breast[J]. J Surg Oncol, 2017, 116(8): 1046-1055.
|
| [28] |
Vlajcic Z, Zic R, Stanec S, et al. Nipple-areola complex preservation: predictive factors of neoplastic nipple-areola complex invasion[J]. Ann Plas Surg, 2005, 55(3): 240-244.
|
| [29] |
Tang R, Coopey SB, Merrill AL, et al. Positive nipple margins in nipple-sparing mastectomies: rates, management, and oncologic safety [J]. J Am Coll Surg, 2016, 222(6): 1149-1155.
|
| [30] |
Lambert PA, Kolm P, Perry RR. Parameters that predict nipple involvement in breast cancer[J]. J Am Coll Surg, 2000, 191(4): 354-359.
|
| [31] |
金纯，郭贵龙，张筱骅. 乳腺癌乳头乳晕复合体侵犯的多因素分析[J]. 浙江医学，2006，28(9): 735-736.
|
| [32] |
Zhang H, Li Y, Moran MS, et al. Predictive factors of nipple involvement in breast cancer: a systematic review and meta-analysis[J]. Breast Cancer Res Treat, 2015, 151(2): 239-249.
|
| [33] |
Lang Z, Wu Y, Li C, et al. Multifocal and multicentric breast carcinoma: a significantly more aggressive tumor than unifocal breast cancer[J]. Anticancer Res, 2017, 37(8): 4593-4598.
|
| [34] |
Mallon P, Feron J, Couturaud B, et al. The role of nipple-sparing mastectomy in breast cancer: a comprehensive review of the literature[J]. Plast Reconstr Surg, 2013, 131(5): 969-984.
|
| [35] |
Santoro S, Loreti A, Cavaliere F, et al. Neoadjuvant chemotherapy is not a contraindication for nipple sparing mastectomy[J]. Breast, 2015, 24(5): 661-666.
|
| [36] |
Reynolds C, Davidson JA, Lindor NM, et al. Prophylactic and therapeutic mastectomy in BRCA mutation carriers: Can the nipple be preserved？[J]. Ann Surg Oncol, 2011, 18(11): 3102-3109.
|
| [37] |
Kneubil MC, Lohsiriwat V, Curigliano G, et al. Risk of locoregional recurrence in patients with false-negative frozen section or close margins of retroareolar specimen in nipple-sparing mastectomy[J]. Ann Surg Oncol, 2012, 19(13): 4117-4123.
|
| [38] |
Govindarajulu S, Narreddy S, Shere MH, et al. Preoperative mammotome biopsy of ducts beneath the nipple areola complex[J]. Eur J Surg Oncol, 2006, 32(4): 410-412.
|
| [39] |
Jakub JW, Peled AW, Gray RJ, et al. Oncologic safety of prophylactic nipple-sparing mastectomy in a population with BRCA mutations[J]. JAMA Surg, 2018, 153(2): 123.
|